Gan & Lee Pharmaceuticals. (SHA:603087)

SHA:603087 Revenue

Gan & Lee Pharmaceuticals. had revenue of 1.15B CNY in the quarter ending September 30, 2026, with 16.91% growth. This brings the company's total for the last twelve months to 4.37B, up 13.69% year-over-year. In the year 2025, Gan & Lee Pharmaceuticals. had annual revenue of 4.05B with 33.06% growth. That makes Gan & Lee Pharmaceuticals. the 9,908th largest company in the world by revenue and 1,594th in China.

• Revenue (ttm): 4.37B
• Revenue Growth: +13.69%
• P/S Ratio: 9.30
• Revenue / Employee: 823.91K
• Employees: 5,309
• Market Cap: 40.55B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 3.51B 86.7%
• International 538.69M 13.3%

Fiscal year ended Dec 31, 2025 See the full SHA:603087 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.05B	1.01B	33.06%
Dec 31, 2024	3.05B	437.31M	16.77%
Dec 31, 2023	2.61B	895.77M	52.31%
Dec 31, 2022	1.71B	-1.90B	-52.60%
Dec 31, 2021	3.61B	250.16M	7.44%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error